ISTH 2025: Favorable nonclinical safety profile of HMB-002 for prophylactic treatment of Von Willebrand disease

June 24, 2025

July 22, 2025

Presented at the ISTH (International Society on Thrombosis and Haemostasis) 2025 Congress

To view the presentation, click here